Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $45.4M
Liabilities Breakdown FY2019
Total Liabilities: $115.7M
Asset Breakdown
Total Assets: $45.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.8M | 39.2% |
| Accounts Receivable | $4.7M | 10.4% |
| Inventory | $8.2M | 18.0% |
| Property, Plant & Equipment | $5.3M | 11.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $9.5M | 20.9% |
Liabilities Breakdown
Total Liabilities: $115.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.9M | 10.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $103.8M | 89.7% |